AIMS To compare the risk of sudden death and non-sudden death from myocardial infarction associated with the metabolic syndrome (MetS) in asymptomatic men. METHODS AND RESULTS The mortality status of 6,678 middle-aged men from the Paris Prospective Study I, who were free of diabetes and coronary heart disease (CHD) at the baseline examination, has been investigated over 21 years of follow-up....

Cardiovascular diseases (CVD) are the most prevalent cause of death and disability in both developed as well as developing countries (Chaturvedi and Bhargava, 2007). According to National Commission on Macroeconomics and Health (NCMH), there would be around 62 million patients with CAD by 2015 in India and out of these 23 million would be patients younger than 40 years of age (Indrayan, 2006). ...

When compared with the general population, the diabetic population is at higher risk of cardiovascular disease (CVD), as predicted by the Framingham Risk Score calculations (10-year risk 20%). For this reason diabetes is considered a "coronary disease equivalent" condition, as classified by the National Cholesterol Education Program Adult Treatment Panel (NCEP-ATP) III. Furthermore, patients wi...

OBJECTIVES To assess the relationship between non-classical cardiovascular (CV) risk factors including non-HDL cholesterol (non-HDL-C), apolipoprotein B, triglycerides to HDL ratio, LDL size, inflammation or oxidative stress parameters and carotid intima-media thickness (CIMT), in order to better identify prevention or therapeutic targets. In addition, we studied the relationship between metabo...

We assessed the impact of the NCEP-III recommendations in a population-based, nation-wide Mexican survey. Information was obtained from 15,607 subjects aged 20 to 69 years. In this report, only samples obtained after a 9 to 12 hours fast are included (2,201 cases). A cardiovascular risk equivalent was found in 10.5% and > or = 2 risk factors were present in 41.7% of the population. In 10% of ca...

BACKGROUND The metabolic syndrome (MetS) is a cluster of risk factors associated with morbidity from cardiovascular disease (CVD) and associated mortality. Russia has one of the highest CVD mortality rates in the world. However, the prevalence of MetS in Russia remains largely unknown. The aim of this study is to estimate the prevalence of MetS and its components in an urban Russian setting. ...

The Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III) provides an evidence-based approach to the diagnosis of dyslipidemia and the management of low-density lipoprotein cholesterol (LDL-C). This article provides a brief overview of the ATP III therapeutic approach (therapeutic life...

Residual coronary heart disease remains a significant problem even after adequate statin therapy for cardiovascular risk reduction as currently recommended by the Adult Treatment Panel III (ATP-III) of the National Cholesterol Education Program (NCEP). This is particularly true for the high risk patients as defined by ATP-III that includes those patients who have a greater than 20% 10-year risk...

background: the prevalence of metabolic syndrome (mets) is increasing worldwide. limited data are available trying to compare different definitions suggested to identify mets. this study aimed to compare the prevalence of mets and its components based on currently available international and iranian national definitions. methods: the present cross-sectional study was conducted in 2015 amongfema...

background: the prevalence of metabolic syndrome (mets) is increasing worldwide. limited data are available trying to compare different definitions suggested to identify mets. this study aimed to compare the prevalence of mets and its components based on currently available international and iranian national definitions. methods: the present cross-sectional study was conducted in 2015 among fem...